Loading clinical trials...
Loading clinical trials...
Evidence suggests that repeated or chronic ketamine use, as compared to acute ketamine users, posed a higher clinical risk of developing psychotic disorders, potentially related to the underlying chro...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
The University of Hong Kong
NCT06413979 · Internalizing Disorders, Substance Use Disorders
NCT05492825 · Substance Use Disorders, Chronic Pain, and more
NCT04197921 · Opioid-use Disorder, Substance Use Disorders
NCT07455929 · Psychotic Disorders, Schizophrenia Spectrum Disorders
NCT07460453 · Paranoia, Psychotic Disorders
Queen Mary Hospital
Hong Kong
Western Psychiatric Centre
Hong Kong
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions